Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
Colloids and Surfaces. B, Biointerfaces|May 30, 2025
Glutathione-triggered ferritin nanoparticles loaded with the myristyl alcohol-modified docetaxel for chemo/chemodynamic therapy and self-sensitized ferroptosisXiaozhou Dong, Fugui Guo, Jingjing Han, et al.Colloids and Surfaces. B, Biointerfaces|June 4, 2024
Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing miceQiuyue Jin, Xiaohui Zhou, Xiaomin Niu, et al.Ecotoxicology and Environmental Safety|March 10, 2023
Toxic effects of maternal cadmium exposure on the metabolism and transport system of amino acids in the maternal liversPeng Xu, Jing Guo, Yaling Jin, et al.Biosensors & Bioelectronics|February 8, 2019
Rapid, label-free genetic detection of enteropathogens in stool without genetic isolation or amplificationSong Han, Mehmet C Soylu, Ceyhun E Kirimli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Fatao Liu, Yi Zhou, et al.Science Translational Medicine|September 4, 2024
PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancerZhuo Chen, Wenxiang Ji, Wenxin Feng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2015
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung CancerRongrong Wei, Lan Cao, Hengying Pu, et al.Lung Cancer (Amsterdam, Netherlands)|November 15, 2025
Threshold of adequate resection margin for sub-lobar resection in peripheral clinical stage IA1-2 non-small cell lung cancer with tumor spread through air spacesHanbo Pan, Hui Yin, Wanyu Li, et al.Clinical Lung Cancer|October 14, 2025
Efficacy of Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma with Tumor Spread Through Air Spaces: A Multi-Center Real-World StudyHanbo Pan, Weiyang Huang, Wanlin Yang, et al.Journal of Hematology & Oncology|May 18, 2022
Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patientsZhen Zhou, Zhengping Ding, Jie Yuan, et al.Pageof 11